CervoMed Inc (CRVO)
24.09
-0.27
(-1.11%)
USD |
NASDAQ |
May 17, 16:00
23.91
-0.18
(-0.75%)
After-Hours: 20:00
CervoMed Free Cash Flow (Quarterly): -1.424M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.424M |
| December 31, 2023 | -2.538M |
| September 30, 2023 | 2.703M |
| June 30, 2023 | -6.132M |
| March 31, 2023 | -1.482M |
| December 31, 2022 | -0.6925M |
| September 30, 2022 | 6.857M |
| June 30, 2022 | -4.007M |
| March 31, 2022 | -4.730M |
| December 31, 2021 | -3.026M |
| September 30, 2021 | -2.972M |
| June 30, 2021 | -3.327M |
| March 31, 2021 | -5.176M |
| December 31, 2020 | -3.395M |
| September 30, 2020 | -3.51M |
| June 30, 2020 | -3.144M |
| March 31, 2020 | -3.504M |
| December 31, 2019 | -2.438M |
| September 30, 2019 | -2.153M |
| June 30, 2019 | -2.610M |
| March 31, 2019 | -2.658M |
| December 31, 2018 | -3.027M |
| September 30, 2018 | -1.916M |
| June 30, 2018 | -2.54M |
| March 31, 2018 | -3.289M |
| Date | Value |
|---|---|
| December 31, 2017 | -2.292M |
| September 30, 2017 | -4.263M |
| June 30, 2017 | -2.804M |
| March 31, 2017 | -3.422M |
| December 31, 2016 | -1.414M |
| September 30, 2016 | -1.865M |
| June 30, 2016 | -2.860M |
| March 31, 2016 | -4.632M |
| December 31, 2015 | -2.293M |
| September 30, 2015 | -0.9844M |
| June 30, 2015 | -1.008M |
| March 31, 2015 | -0.941M |
| December 31, 2014 | -1.930M |
| September 30, 2014 | -1.979M |
| June 30, 2014 | -4.688M |
| March 31, 2014 | -0.4329M |
| December 31, 2013 | -0.0006M |
| September 30, 2013 | -0.333M |
| June 30, 2013 | -0.5448M |
| March 31, 2013 | -0.3062M |
| December 31, 2012 | -1.498M |
| September 30, 2012 | -0.5593M |
| June 30, 2012 | -0.4073M |
| March 31, 2012 | -1.846M |
| December 31, 2011 | -3.217M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-6.132M
Minimum
Jun 2023
6.857M
Maximum
Sep 2022
-2.335M
Average
-2.999M
Median
Free Cash Flow (Quarterly) Benchmarks
| GlucoTrack Inc | -2.411M |
| AIM ImmunoTech Inc | -9.956M |
| Perspective Therapeutics Inc | 4.776M |
| Protalix BioTherapeutics Inc | 3.59M |
| Armata Pharmaceuticals Inc | -10.83M |